Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a large drop in short interest in February. As of February 27th, there was short interest totaling 10,141 shares, a drop of 50.5% from the February 12th total of 20,471 shares. Based on an average daily volume of 18,389 shares, the short-interest ratio is currently 0.6 days. Approximately 0.4% of the company’s stock are short sold. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 18,389 shares, the short-interest ratio is currently 0.6 days.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. WMS Group LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter worth about $4,255,000. LPL Financial LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter worth about $1,220,000. Independent Advisor Alliance acquired a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at approximately $653,000. GeoWealth Management LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF in the 3rd quarter valued at $451,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Invesco Nasdaq Biotechnology ETF by 7.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 215,722 shares of the company’s stock valued at $5,245,000 after purchasing an additional 14,717 shares in the last quarter.
Invesco Nasdaq Biotechnology ETF Price Performance
IBBQ traded down $0.13 during midday trading on Friday, hitting $28.46. 4,261 shares of the company’s stock traded hands, compared to its average volume of 41,324. The stock’s fifty day simple moving average is $29.32 and its 200-day simple moving average is $27.41. Invesco Nasdaq Biotechnology ETF has a one year low of $17.84 and a one year high of $30.49. The company has a market cap of $71.43 million, a PE ratio of 17.03 and a beta of 0.67.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Articles
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- The “secret weapon” behind Microsoft, Meta, Amazon, and Google
- A personal warning from Martin Weiss (Please read)
- The largest IPO in history is coming
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- 17,556% on WHAT?
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
